☰

Troy A. McEachron, Ph.D. - Publications

Affiliations: 
2011 Pathology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pathology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mannheimer JD, Tawa G, Gerhold D, Braisted J, Sayers CM, McEachron TA, Meltzer P, Mazcko C, Beck JA, LeBlanc AK. Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans. Communications Biology. 6: 856. PMID 37591946 DOI: 10.1038/s42003-023-05208-z  0.31
2020 Hingorani P, Dinu V, Zhang X, Lei H, Shern JF, Park J, Steel J, Rauf F, Parham D, Gastier-Foster J, Hall D, Hawkins DS, Skapek SX, Labaer J, McEachron TA. Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology Group. Scientific Reports. 10: 12318. PMID 32703985 DOI: 10.1038/S41598-020-69015-W  0.412
2020 Gibbs LD, Williams SR, Weisenfeld NI, Bassiouni R, Delaney NF, Silva DD, Yin Y, Rotimi S, Chew J, Frey M, Qian J, Miller H, Murderspach L, McEachron T, Craig D, et al. Abstract A087: Spatial RNA-seq reveals intratumor heterogeneity and transcriptional substructure in a diverse cohort of high-grade ovarian cancers Cancer Epidemiology, Biomarkers & Prevention. 29. DOI: 10.1158/1538-7755.Disp19-A087  0.437
2020 Gibbs LD, Byun J, Yan T, Napoles A, Pere-Stables E, McEachron T, Vohra N, Carpten JD, Gardner K. Abstract B055: Characterization of immune cell subsets from tissue expression profiles in African American triple-negative breast cancer patients Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-B055  0.384
2020 Sorenson L, McEachron TA. Abstract A77: Targeting lymphocyte exclusion in metastatic osteosarcoma Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-A77  0.471
2020 Gibbs LD, Williams SR, Weisenfeld NI, Craig DW, Bassiouni R, Delaney NF, Silva DD, Yin Y, Rotimi S, Chew J, Frey M, Webb M, Qian J, Miller H, Murderspach L, ... McEachron T, et al. Abstract NG03: Spatial RNA-seq reveals intratumor heterogeneity and transcriptional substructure in high-grade ovarian cancers Tumor Biology. DOI: 10.1158/1538-7445.Am2020-Ng03  0.305
2020 Sadeghi S, Hether T, Yeon J, Mangio R, Reeves J, Liang Y, Warren S, McEachron T, Gill P. 455 Impact of EphB4 and PD-1 treatment on immune infiltrate in advanced bladder cancer Journal For Immunotherapy of Cancer. 8: A482-A482. DOI: 10.1136/jitc-2020-sitc2020.0455  0.363
2019 Sorenson L, Fu Y, Hood T, Warren S, McEachron TA. Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma. Oncoimmunology. 8: e1629779. PMID 31428529 DOI: 10.1080/2162402X.2019.1629779  0.442
2019 Gibbs LD, Qian J, Webb M, Chang S, Manojlovic Z, Velazquez EI, McEachron T, Craig DW, Carpten JD. Abstract 4703: Single Cell CNV End to End workflow to uncover tumor heterogeneity in a murine breast cancer model Cancer Research. 79: 4703-4703. DOI: 10.1158/1538-7445.Am2019-4703  0.48
2018 McEachron TA, Triche TJ, Sorenson L, Parham DM, Carpten JD. Profiling targetable immune checkpoints in osteosarcoma. Oncoimmunology. 7: e1475873. PMID 30524885 DOI: 10.1080/2162402X.2018.1475873  0.456
2017 McEachron TA. Abstract IA36: Caught in the middle: Viewing adolescent/young adult oncology patients as the medically underserved Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-Ia36  0.324
2016 McEachron TA, Kirov I, Wungwattana M, Cortes D, Zabokrtsky KB, Sassoon A, Craig D, Carpten JD, Sender LS. Successful Treatment of Genetically Profiled Pediatric Extranodal NK/T-Cell Lymphoma Targeting Oncogenic STAT3 Mutation. Pediatric Blood & Cancer. 63: 727-30. PMID 26727971 DOI: 10.1002/Pbc.25854  0.381
2016 Hingorani P, McEachron T, Park J, Steel J, Gastier-Foster JM, Rodriguez-Galindo C, Skapek S, Hawkins DS, LaBaer J, Dinu V. RNA profiling of desmoplastic small round cell tumors (DSRCTs) using next-generation sequencing. Journal of Clinical Oncology. 34: 10552-10552. DOI: 10.1200/Jco.2016.34.15_Suppl.10552  0.39
2016 McEachron TA, Zabokrtsky KB, Sassoon AF, Nasser S, Izatt T, Garner CP, Craig DW, Carpten JD, Sender LS. Abstract PR06: Precision medicine for newly diagnosed and refractory/recurrent pediatric cancer patients: Lessons learned from “N=1” studies Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pmsclingen15-Pr06  0.388
2016 McEachron TA, Zabokrtsky KB, Sassoon A, Manoljvic Z, Craig DW, Carpten JD, Sender LS. Abstract A42: Precision medicine for pediatric, adolescent, and young adult patients with newly diagnosed or refractory/recurrent cancer: Lessons learned from N=1 studies on rare tumors Cancer Research. 76. DOI: 10.1158/1538-7445.Pedca15-A42  0.394
2015 Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WPD, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, Shah SP, Prentice LM, Marra MA, Kiefer J, Zismann VL, ... McEachron TA, et al. Abstract POSTER-BIOL-1327: Small cell carcinoma of the ovary, hypercalcemic type displays frequent inactivating germline and somatic mutations in SMARCA4 Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Biol-1327  0.466
2014 Liu X, McEachron TA, Schwartzentruber J, Wu G. Histone H3 mutations in pediatric brain tumors. Cold Spring Harbor Perspectives in Biology. 6: a018689. PMID 24691963 DOI: 10.1101/Cshperspect.A018689  0.367
2014 Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WP, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, Shah SP, Prentice LM, Marra MA, Kiefer J, Zismann VL, ... McEachron TA, et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nature Genetics. 46: 427-9. PMID 24658001 DOI: 10.1038/Ng.2928  0.416
2014 Zabokrtsky KB, Garner CP, McEachron T, Mosher N, Darwish AG, Sender LS. Abstract A34: Creation of a personalized, molecular-based approach to the treatment of recurrent or refractory pediatric and adolescent cancers Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A34  0.426
2014 Ramos P, Karnezis A, Craig D, Sekulic A, Russell M, Hendricks W, Barrett M, Shumansky K, Yang Y, Shah S, Prentice L, Marra M, Kiefer J, Zismann V, McEachron T, et al. Abstract LB-202: The rare, highly malignant small cell carcinoma of the ovary displays common inactivating germline and somatic mutations in the tumor suppressor SMARCA4 Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-202  0.483
2014 Ramos P, Karnezis AN, Craig DW, Sekulic A, Russel ML, Hendricks WPD, Corneveaux JJ, Barrett MT, Shumansky K, Yang Y, Shah SP, Prentice LM, Marra MA, Kiefer J, Zismann VL, ... McEachron TA, et al. Corrigendum: Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 Nature Genetics. 46: 759-759. DOI: 10.1038/Ng0714-759A  0.319
2013 McEachron TA, Tomboc P, Tran NL. An integrated approach to identifying clinically relevant targets in pediatric gliomas. Cns Oncology. 2: 303-6. PMID 25054574 DOI: 10.2217/Cns.13.21  0.38
2013 Larson JD, McEachron TA, Qu C, Zhu X, Diaz AK, Ellison DW, Orr BA, Baker SJ. Abstract A15: Variant histone H3 mutations associate with histone modification, DNA methylation, and gene expression changes in pediatric high-grade gliomas Cancer Research. 73. DOI: 10.1158/1538-7445.Cec13-A15  0.338
2012 Kasthuri RS, Glover SL, Jonas W, McEachron T, Pawlinski R, Arepally GM, Key NS, Mackman N. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI. Blood. 119: 5285-93. PMID 22394597 DOI: 10.1182/Blood-2011-06-359430  0.34
2011 McEachron TA, Church FC, Mackman N. Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 22: 576-82. PMID 21799402 DOI: 10.1097/Mbc.0B013E3283497647  0.611
2010 McEachron TA, Pawlinski R, Richards KL, Church FC, Mackman N. Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis. Blood. 116: 5037-44. PMID 20736455 DOI: 10.1182/Blood-2010-06-293126  0.63
2010 McEachron T, Church F, Mackman N. Abstract 1251: Increased expression of the plasminogen activator system due to differential protease-activated receptor signaling in breast cancer cells Cancer Research. 70: 1251-1251. DOI: 10.1158/1538-7445.Am10-1251  0.64
2009 Mceachron T, Mackman N. Tumors, ticks and tissue factor. Journal of Thrombosis and Haemostasis. 7: 1852-1854. PMID 19694942 DOI: 10.1111/J.1538-7836.2009.03592.X  0.508
Show low-probability matches.